Spectral AI, Inc. announced on February 7, 2025, the completion of its data analytics for the U.S. Burn Pivotal Study. This study is designed to validate the AI-driven algorithm used by the company’s DeepView System for burn indication.
The company reported that the results reflect strong metrics for the DeepView System when compared to burn and emergency room physicians in determining the wound healing potential of burns. This indicates positive clinical validation of the technology.
These successful data analysis results are a critical step towards the planned FDA submission. The DeepView System aims to provide an immediate and binary prediction of wound healing, benefiting clinical decision-making regarding treatment plans.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.